Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.08 (-16.67%)
Close on Nov 12, 2026Market cap $2.07MP/E –Yield –
Jaguar Health operating margin
Operating margin is operating income as a percentage of revenue.
Jaguar Health's operating margin for the twelve months ending Jun 30, 2026 was -93.1%. For fiscal 2025 it was -398.8%, against -263.8% the year before. The highest annual figure on record is -263.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -398.8% | −135.1 |
| FY2024 | Dec 31, 2024 | -263.8% | +87.5 |
| FY2023 | Dec 31, 2023 | -351.3% | −63.5 |
| FY2022 | Dec 31, 2022 | -287.8% | +651.2 |
| FY2021 | Dec 31, 2021 | -939.1% | −655.1 |
| FY2020 | Dec 31, 2020 | -283.9% | +217.3 |
| FY2019 | Dec 31, 2019 | -501.3% | +196.7 |
| FY2018 | Dec 31, 2018 | -698.0% | +87.3 |
| FY2017 | Dec 31, 2017 | -785.3% | +8814.6 |
| FY2016 | Dec 31, 2016 | -9599.8% | −4783.2 |
| FY2015 | Dec 31, 2015 | -4816.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -620.2% | −351.4 |
| Q1 FY2026 | Mar 31, 2026 | 50.2% | +475.7 |
| Q4 FY2025 | Dec 31, 2025 | -656.6% | −424.2 |
| Q3 FY2025 | Sep 30, 2025 | -234.8% | −1.1 |
| Q2 FY2025 | Jun 30, 2025 | -268.8% | −4.3 |
| Q1 FY2025 | Mar 31, 2025 | -425.5% | −76.1 |
| Q4 FY2024 | Dec 31, 2024 | -232.5% | +96.1 |
| Q3 FY2024 | Sep 30, 2024 | -233.7% | +78.7 |
| Q2 FY2024 | Jun 30, 2024 | -264.5% | −63.9 |
| Q1 FY2024 | Mar 31, 2024 | -349.4% | −155.6 |
| Q4 FY2023 | Dec 31, 2023 | -328.6% | −61.7 |
| Q3 FY2023 | Sep 30, 2023 | -312.4% | +568.4 |
| Q4 FY2020 | Dec 31, 2020 | -200.6% | +185.9 |
| Q3 FY2020 | Sep 30, 2020 | -193.8% | +497.5 |
| Q2 FY2020 | Jun 30, 2020 | -266.8% | +355.8 |
| Q1 FY2020 | Mar 31, 2020 | -880.8% | −517.6 |
| Q4 FY2019 | Dec 31, 2019 | -386.5% | +372.4 |
| Q3 FY2019 | Sep 30, 2019 | -691.4% | −116.6 |
| Q2 FY2019 | Jun 30, 2019 | -622.6% | +718.5 |
| Q1 FY2019 | Mar 31, 2019 | -363.2% | +303.9 |
| Q4 FY2018 | Dec 31, 2018 | -758.9% | −496.7 |
| Q3 FY2018 | Sep 30, 2018 | -574.7% | −103.5 |
| Q4 FY2017 | Dec 31, 2017 | -1341.2% | +10135.3 |
| Q3 FY2017 | Sep 30, 2017 | -667.2% | +5645.4 |
| Q2 FY2017 | Jun 30, 2017 | -262.2% | +13855.2 |
| Q1 FY2017 | Mar 31, 2017 | -471.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -11476.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -6312.6% | – |
| Q2 FY2016 | Jun 30, 2016 | -14117.4% | – |
See a number that looks wrong?